Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Tumor-derived exosomes co-delivering aggregation-induced emission luminogens and proton pump inhibitors for tumor glutamine starvation therapy and enhanced type-I photodynamic therapy — Daoming Zhu (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Tumor-derived exosomes co-delivering aggregation-induced emission luminogens and proton pump inhibitors for tumor glutamine starvation therapy and enhanced type-I photodynamic therapy
BT
Shared by
Ben Zhong Tang
Tumor-derived exosomes co-delivering aggregation-induced emission luminogens and proton pump inhibitors for tumor glutamine starvation therapy and enhanced type-I photodynamic therapy
Article
2022
en
Authors
+6 more
DZ
Daoming Zhu
TZ
Tianfu Zhang
LY
Li Yang
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Recent Progress in Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy
Yuewen Yu
,
Hanyu Jia
,
Yubo Liu
,
Le Zhang
,
Guangxue Feng
,
Ben Zhong Tang
Article
2024
Anthraquinone-Centered Type I Photosensitizer with Aggregation-Induced Emission Characteristics for Tumor-Targeted Two-Photon Photodynamic Therapy
Wenguang Zhang
,
Xue Li
,
Miaomiao Kang
,
Zhijun Zhang
,
Yutao Pei
,
Miaozhuang Fan
,
Dingyuan Yan
,
Yibin Zhang
,
Chengbin Yang
,
Gaixia Xu
,
Dong Wang
,
Zhourui Xu
,
Ben Zhong Tang
Article
2022
NIR-II Aggregation-Induced Emission Luminogens for Tumor Phototheranostics
Yonghong Tan
,
Peiying Liu
,
Danxia Li
,
Dong Wang
,
Ben Zhong Tang
Article
2022
Type I Photosensitizers Based on Aggregation-Induced Emission: A Rising Star in Photodynamic Therapy
Danxia Li
,
Peiying Liu
,
Yonghong Tan
,
Zhijun Zhang
,
Miaomiao Kang
,
Dong Wang
,
Ben Zhong Tang
Article
2025
Frontiers in photodynamic therapy: type I NIR-II photosensitizers with aggregation-induced emission features
Tong Ye
,
Xue Li
,
Dong Wang
,
Ben Zhong Tang
Discussion(0)
No comments yet. Be the first to comment.